|
RNF41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.734000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.938220E-02 |
| Normal-vs-Stage2 |
1.986390E-01 |
| Normal-vs-Stage3 |
9.721400E-01 |
| Normal-vs-Stage4 |
9.789000E-01 |
| Stage1-vs-Stage2 |
8.442400E-01 |
| Stage1-vs-Stage3 |
1.914950E-01 |
| Stage1-vs-Stage4 |
5.462600E-01 |
| Stage2-vs-Stage3 |
3.574400E-01 |
| Stage2-vs-Stage4 |
6.221200E-01 |
| Stage3-vs-Stage4 |
9.692600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.019600E-02 |
| Normal-vs-AfricanAmerican |
6.313800E-01 |
| Normal-vs-Asian |
1.571220E-01 |
| Caucasian-vs-AfricanAmerican |
3.686600E-01 |
| Caucasian-vs-Asian |
4.461800E-01 |
| AfricanAmerican-vs-Asian |
2.918600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.908100E-02 |
| Normal-vs-Female |
9.643400E-01 |
| Male-vs-Female |
1.087960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.869580E-02 |
| Normal-vs-Extreme_Weight |
1.457710E-02 |
| Normal-vs-Obese |
8.276600E-01 |
| Normal-vs-Extreme_Obese |
1.090200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.330000E-01 |
| Normal_Weight-vs-Obese |
8.972100E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.223000E-01 |
| Extreme_Weight-vs-Obese |
8.591700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.433600E-01 |
| Obese-vs-Extreme_Obese |
2.468200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.520600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.916800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.443300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.889700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.291790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.741100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.473650E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.646110E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.275990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.859600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.787620E-01 |
| Normal-VS-Type2 PRCC |
1.718090E-03 |
| Normal-VS-KIRP CIMP |
2.598000E-01 |
| Normal-VS-Unclassified PRCC |
4.381600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.842100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.778400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.785960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.635900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.555700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.069800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.082600E-03 |
| Normal-vs-N1 |
4.729400E-01 |
| Normal-vs-N2 |
1.596290E-02 |
| N0-vs-N1 |
3.978400E-02 |
| N0-vs-N2 |
2.146400E-02 |
| N1-vs-N2 |
5.713000E-01 |
|
|
